Search Results - "BARONCIANI, DONATELLA"
-
1
Allogeneic stem cell transplantation for thalassemia major
Published in Haematologica (Roma) (01-12-2008)Get full text
Journal Article -
2
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
Published in Haematologica (Roma) (01-07-2007)“…From the Laboratory of Cellular and Gene Therapy "G. Lanzani", Ospedali Riuniti di Bergamo, Bergamo, Italy (MI, GB, EC, MF, JG); Division of Hematology,…”
Get full text
Journal Article -
3
Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation
Published in Blood (01-07-2002)“…To identify the role of iron overload in the natural history of liver fibrosis, we reviewed serial hepatic biopsy specimens taken annually from patients cured…”
Get full text
Journal Article -
4
Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
Published in The New England journal of medicine (03-08-2000)“…Quantitative studies of iron balance in patients with thalassemia major have been limited by the lack of a method for determining the total amount of stored…”
Get full text
Journal Article -
5
Selecting β‐thalassemia Patients for Gene Therapy: A Decision‐making Algorithm
Published in HemaSphere (01-05-2021)“…This expert opinion originally developed by a panel of the Italian Society of Thalassemias and Hemoglobinopathies (SITE), reviewed and adopted by the European…”
Get full text
Journal Article -
6
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
Published in Haematologica (Roma) (01-05-2014)“…Thalassemia major and sickle cell disease are the two most widely disseminated hereditary hemoglobinopathies in the world. The outlook for affected individuals…”
Get full text
Journal Article -
7
-
8
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
Published in Bone marrow transplantation (Basingstoke) (01-06-2022)“…The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment represents an unmet clinical need. However, allogeneic…”
Get full text
Journal Article -
9
Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm
Published in Blood (13-11-2019)“…Introduction and Aim Till today, the only curative and most widely used therapy for β-thalassemia (β-TDT) is allogeneic HSCT: the European Society for Bone…”
Get full text
Journal Article -
10
Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017
Published in Blood (29-11-2018)“…▪ INTRODUCTION: Allogeneic hematopoietic cell transplantation (HCT) is a diffuse curative option for transfusion dependent thalassemia (TDT) and sickle cell…”
Get full text
Journal Article -
11
Reproducibility of liver iron concentration measured on a biopsy sample: A validation study in vivo
Published in American journal of hematology (01-02-2015)“…Determination of liver iron concentration is essential to predict iron related tissue damage and to guide chelation therapy. To assess the reliability of a…”
Get full text
Journal Article -
12
Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study
Published in Blood (06-12-2014)“…Background. Autologous stem cell transplant is a consolidation treatment for standard risk acute myeloid leukemia (AML). Traditional preparative regimens, most…”
Get full text
Journal Article -
13
Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation
Published in Blood (06-12-2014)“…▪ Background. Allogeneic hemopoietic stem cell transplantation is the treatment of choice for high and intermediate risk acute myeloid leukemia (AML) and for…”
Get full text
Journal Article -
14
Biosimilars G‐CSF versus originator G‐CSF in post allotransplant recovery. A case–control study
Published in American journal of hematology (01-02-2016)Get full text
Journal Article -
15
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
Published in Blood (15-08-2004)“…When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY) 120 to 160 mg/kg, patients with thalassemia in risk class 3, aged…”
Get full text
Journal Article -
16
Role of Allogeneic Stem Cell Transplantation (AlloSCT) in Patients Affected By Peripheral T-Cell Lymphomas (PTCL): No Difference in Outcome Between Patients Allografted at Diagnosis and in First Chemosensitive Relapse
Published in Blood (06-12-2014)“…Introduction: Despite novel therapies are under investigation in peripheral T-cell lymphomas (PTCL), the majority of the patients (pts) still have a dismal…”
Get full text
Journal Article -
17
Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study
Published in Blood (15-11-2013)“…The management of high dose chemotherapy followed by autologous or allogeneic hemopoietic stem cell transplantation requires an intravenous line for…”
Get full text
Journal Article -
18
Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre study
Published in Hematological oncology (01-03-2016)“…In recent years, with the aim of reducing transplant‐related mortality, new conditioning regimens have been explored in patients not eligible for conventional…”
Get full text
Journal Article -
19
Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Published in Clinical infectious diseases (15-10-2009)“…In recent years, prospective studies have been conducted to assess the role of prophylaxis and treatment of invasive fungal diseases (IFD) in allogeneic…”
Get full text
Journal Article -
20
Hematopoietic Stem Cell Transplantation in Thalassemia Major. Report from the EBMT Hemoglobinopathy Registry
Published in Blood (18-11-2011)“…Abstract 905 Hemopoietic allogeneic stem cell transplantation (HSCT) still remains the only available curative option for β-thalassaemia major. At today more…”
Get full text
Journal Article